Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burkhard Greve

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 10, 2018
miR-142-3p attenuates breast cancer stem cell characteristics and decreases radioresistance in vitroFabian M Troschel, Nicolas Böhly, Katrin Borrmann, et al.
International Journal of Cancer|December 18, 2010
The adult stem cell marker Musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosis via Notch-1 and p21WAF1/CIP1Martin Götte, Burkhard Greve, Reinhard Kelsch, et al.
Fertility and Sterility|January 15, 2013
MicroRNA miR-145 inhibits proliferation, invasiveness, and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factorsMarlene Adammek, Burkhard Greve, Nadja Kässens, et al.
Cells|October 28, 2025
The Role of the Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 in Breast Cancer PathophysiologyLena Habenicht, Nourhan Hassan, Nancy A Espinoza-Sànchez, et al.
IUBMB Life|May 19, 2022
The heparan sulphate proteoglycan Syndecan-1 (CD138) regulates tumour progression in a 3D model of ductal carcinoma in situ of the breastChristopher D'Arcy, Clarissa Constanze Zimmermann, Nancy Adriana Espinoza-Sanchez, et al.
Reproductive Biomedicine Online|April 1, 2022
Resveratrol impairs cellular mechanisms associated with the pathogenesis of endometriosisDaniela Madanes, Gabriela Meresman, Sofía A Valla, et al.
Fertility and Sterility|December 5, 2012
Targeting of syndecan-1 by micro-ribonucleic acid miR-10b modulates invasiveness of endometriotic cells via dysregulation of the proteolytic milieu and interleukin-6 secretionCornelia Schneider, Nadja Kässens, Burkhard Greve, et al.
Stem Cell Research & Therapy|May 26, 2022
Knockdown of the stem cell marker Musashi-1 inhibits endometrial cancer growth and sensitizes cells to radiationIsabel Falke, Fabian M Troschel, Heike Palenta, et al.
Journal of Cellular Biochemistry|January 11, 2022
The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patientsIris Kahl, Julian Mense, Christopher Finke, et al.
Cells|February 25, 2022
Digital Holographic Microscopy for Label-Free Detection of Leukocyte Alternations Associated with Perioperative Inflammation after Cardiac SurgeryDavid Rene Steike, Michael Hessler, Eberhard Korsching, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 10, 2018
miR-142-3p attenuates breast cancer stem cell characteristics and decreases radioresistance in vitroFabian M Troschel, Nicolas Böhly, Katrin Borrmann, et al.
International Journal of Cancer|December 18, 2010
The adult stem cell marker Musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosis via Notch-1 and p21WAF1/CIP1Martin Götte, Burkhard Greve, Reinhard Kelsch, et al.
Fertility and Sterility|January 15, 2013
MicroRNA miR-145 inhibits proliferation, invasiveness, and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factorsMarlene Adammek, Burkhard Greve, Nadja Kässens, et al.
Cells|October 28, 2025
The Role of the Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 in Breast Cancer PathophysiologyLena Habenicht, Nourhan Hassan, Nancy A Espinoza-Sànchez, et al.
IUBMB Life|May 19, 2022
The heparan sulphate proteoglycan Syndecan-1 (CD138) regulates tumour progression in a 3D model of ductal carcinoma in situ of the breastChristopher D'Arcy, Clarissa Constanze Zimmermann, Nancy Adriana Espinoza-Sanchez, et al.
Reproductive Biomedicine Online|April 1, 2022
Resveratrol impairs cellular mechanisms associated with the pathogenesis of endometriosisDaniela Madanes, Gabriela Meresman, Sofía A Valla, et al.
Fertility and Sterility|December 5, 2012
Targeting of syndecan-1 by micro-ribonucleic acid miR-10b modulates invasiveness of endometriotic cells via dysregulation of the proteolytic milieu and interleukin-6 secretionCornelia Schneider, Nadja Kässens, Burkhard Greve, et al.
Stem Cell Research & Therapy|May 26, 2022
Knockdown of the stem cell marker Musashi-1 inhibits endometrial cancer growth and sensitizes cells to radiationIsabel Falke, Fabian M Troschel, Heike Palenta, et al.
Journal of Cellular Biochemistry|January 11, 2022
The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patientsIris Kahl, Julian Mense, Christopher Finke, et al.
Cells|February 25, 2022
Digital Holographic Microscopy for Label-Free Detection of Leukocyte Alternations Associated with Perioperative Inflammation after Cardiac SurgeryDavid Rene Steike, Michael Hessler, Eberhard Korsching, et al.
Pageof 9